BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15488313)

  • 1. Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's disease.
    Huerta C; Alvarez V; Mata IF; Coto E; Ribacoba R; Martínez C; Blázquez M; Guisasola LM; Salvador C; Lahoz CH; Peña J
    Neurosci Lett; 2004 Nov; 370(2-3):151-4. PubMed ID: 15488313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
    Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
    Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR2-64I polymorphism and CCR5Delta32 deletion in patients with Alzheimer's disease.
    Galimberti D; Fenoglio C; Lovati C; Gatti A; Guidi I; Venturelli E; Cutter GR; Mariani C; Forloni G; Pettenati C; Baron P; Conti G; Bresolin N; Scarpini E
    J Neurol Sci; 2004 Oct; 225(1-2):79-83. PubMed ID: 15465089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
    Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
    Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of chemokine and chemokine receptor genes in Type 1 diabetes mellitus and its complications.
    Yang B; Houlberg K; Millward A; Demaine A
    Cytokine; 2004 May; 26(3):114-21. PubMed ID: 15135805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
    Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
    Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CCR5-delta32 mutation: impact on disease outcome in individuals with hepatitis C infection from a single source.
    Goulding C; McManus R; Murphy A; MacDonald G; Barrett S; Crowe J; Hegarty J; McKiernan S; Kelleher D
    Gut; 2005 Aug; 54(8):1157-61. PubMed ID: 15863470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction.
    González P; Alvarez R; Batalla A; Reguero JR; Alvarez V; Astudillo A; Cubero GI; Cortina A; Coto E
    Genes Immun; 2001 Jun; 2(4):191-5. PubMed ID: 11477473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C.
    Promrat K; McDermott DH; Gonzalez CM; Kleiner DE; Koziol DE; Lessie M; Merrell M; Soza A; Heller T; Ghany M; Park Y; Alter HJ; Hoofnagle JH; Murphy PM; Liang TJ
    Gastroenterology; 2003 Feb; 124(2):352-60. PubMed ID: 12557141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.
    Bogner JR; Lutz B; Klein HG; Pollerer C; Troendle U; Goebel FD
    HIV Med; 2004 Jul; 5(4):264-72. PubMed ID: 15236615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association of human chemokine receptor gene polymorphisms CCR2-64I and CCR5-Delta32 with autoimmune Addison's disease.
    Gambelunghe G; Ghaderi M; Gharizadeh B; Brozzetti A; Tortoioli C; Del Sindaco P; Sanjeevi CB; Hjelmström P; Sirsjö A; Nyren P; Santeusanio F; Falorni A
    Eur J Immunogenet; 2004 Apr; 31(2):73-6. PubMed ID: 15086346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis.
    Ahad MA; Missotten T; Abdallah A; Lympany PA; Lightman S
    Mol Vis; 2007 Mar; 13():388-96. PubMed ID: 17417600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypes of CCR2 and CCR5 chemokine receptors in human myasthenia gravis.
    Zhao X; Gharizadeh B; Hjelmström P; Pirskanen R; Nyrén P; Lefvert AK; Ghaderi M
    Int J Mol Med; 2003 Nov; 12(5):749-53. PubMed ID: 14533004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan.
    Konishi I; Horiike N; Hiasa Y; Michitaka K; Onji M
    Intervirology; 2004; 47(2):114-20. PubMed ID: 15192276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease.
    Nishimura M; Kuno S; Mizuta I; Ohta M; Maruyama H; Kaji R; Kawakami H
    Mov Disord; 2003 Aug; 18(8):953-5. PubMed ID: 12889089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine receptor CCR2/CCR5 polymorphism in Spanish patients with systemic lupus erythematosus.
    Aguilar F; Núñez-Roldán A; Torres B; Wichmann I; Sánchez-Román J; González-Escribano MF
    J Rheumatol; 2003 Aug; 30(8):1770-4. PubMed ID: 12913933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case-control association of RANTES (-28C >G) and CCR5-Delta32 polymorphisms with Parkinson's disease in Indians.
    Subramanian N; Ramanathan S; Paul SFD; Venkatesan V; Koshy T
    Neurosci Lett; 2020 Nov; 739():135404. PubMed ID: 32987132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus.
    Liao CH; Yao TC; Chung HT; See LC; Kuo ML; Huang JL
    J Rheumatol; 2004 Oct; 31(10):2062-7. PubMed ID: 15468376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus.
    Lima G; Soto-Vega E; Atisha-Fregoso Y; Sánchez-Guerrero J; Vallejo M; Vargas-Alarcón G; Llorente L
    Hum Immunol; 2007 Dec; 68(12):980-5. PubMed ID: 18191726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.